ã¤ãã¨ãã°ãã¨ããããåä½ã£ã½ããªã
ãå»è ããã«LINEã§ç¸è«ã§ãããµã¼ãã¹ãLINEãã«ã¹ã±ã¢ãããæ©ã人ã«å¯¾ãã¦ãæ»ã¬ã®ãæ£è§£ããä½ã¬ãã«ããã¬ãã³ãã§ãã¨è¨ãæ¾ã¤æ§åãSNSã§æ¡æ£ãçä¸ã8æ2æ¥ä»ãã§LINEãã«ã¹ã±ã¢ããã客æ§ã®ãå¿ãå·ã¤ããå¤å¤§ãªããè¿·æãããããã¾ãããã¨ãæ·±ããè©«ã³ç³ãä¸ãã¾ããã¨è¬ç½ªãã¾ããã LINEãã«ã¹ã±ã¢ã¯ããå°éæ§ãæã£ãå»å¸«ãç¸è«ã«çãããã®ãç¹å¾´ãç¾å¨ã¯COVID-19ï¼æ°åã³ããã¦ã¤ã«ã¹ææçï¼ã®æ¡å¤§é²æ¢ã«åãã¦ãæééå®ã§ç¡åã§ã®ãµã¼ãã¹æä¾ãè¡ã£ã¦ãã¾ãããé常ã¯ããã¾ããç¸è«ãã/ ç¸è«ãäºç´ãããã30å2000åã1000æå以å ã®è³ªåã«å¯¾ãã¦ããã¨ããåçãããããã1000åã®ææãµã¼ãã¹ã§ãã LINEãã«ã¹ã±ã¢ï¼å ¬å¼ãµã¤ãããï¼ ç¾å¨ã¯æééå®ã§ç¡æã§å©ç¨å¯è½ã ã¨ããï¼å ¬å¼ãµã¤ãããï¼ ç©è°ãé¸ãã¦ããã®ã¯ãç¸è«ã®æ§åãæ®å½±ããã¨ããã¹ã¯ãªã¼ã³ã·ã§ããç»åã
å æ¥ã®å°æ²¢å¥äºã®ãã¤ã¼ãã«ã¤ãã¦ã140æåã§ã¯æ¸ããããªãã®ã§ãæ¹ãã¦ãã®åé¡ç¹ãããã§èª¬æãããã¨æããçºç«¯ã¯7æ26æ¥ã®ãã®ãã¤ã¼ãã ã£ãã ã¾ãè¦ã¦ãåããã®éãããã¡ããã¡ãè ¹ãç«ã£ããç§ä»¥å¤ã«ãããã®ãã¤ã¼ãã«è ¹ãç«ã¦ãããããã¯åé¡è¦ãã人ã大å¢ãã¦ããããããã¤ãã¿ã¼ä¸ã®ãçä¸ãã¨ããç¶æ ãæããã èªåã®ãã®ãã¤ã¼ãã«ã¤ãã¦ãä¸ã¤è¨æ£ãããã®ã¯ããçµäºãâãã¨æ¸ãããã¨ã ãããã¯ãããããä»ããã£ã³ã»ã«ã»ã«ã«ãã£ã¼ãã¨å¼ã°ãããã®ã®å ¸åã§ãããä¸ã¤ã®çºè¨ãæ稿ã ããåãä¸ãã¦ç¸æãå ¨å¦å®ããã®ã¯è¯ããªãï¼ãã ããç§ã¯ãã£ã³ã»ã«ã»ã«ã«ãã£ã¼ã®æ義ãå ¨å¦å®ã¯ããªãï¼ããçµäºãã¨ããè¨èã¯ãã®å¾ã®å¦ã³ãä¿®æ£ã®å¯è½æ§ãå¦å®ãã¦ãã¾ãç©è¨ãã§ãããããã¯æ¹å¤ã§ã¯ãªãå ¨é¢å¦å®ãæå³ããã®ã§ãããã§ã¯ä¸é©åã§ãã£ãããã®é¨åã¯æ¤åãããããçµäºããããã¨ãªããä¿®æ£ãã¦ãããã®ãªããã®æ¹
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}